MSVEX — Vitality Portfolio
Data updated: 2026-05-28
MSVEX — Vitality Portfolio. United States Multi-Cap / All-Cap Growth Materials Equity · $2.14M AUM. Holdings, fees, performance and SEC filings.
MSVEX Fund Overview
MSVEX — Vitality Portfolio is a US mutual fund managed by Morgan Stanley Institutional Fund INC, categorised as United States Multi-Cap / All-Cap Growth Materials Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Morgan Stanley Institutional Fund INC
- Category: United States Multi-Cap / All-Cap Growth Materials Equity
- Assets under management: $2.14M
- 1-year return: 14.7%
- Ticker: MSVEX
- SEC CIK: 0000836487
- SEC series ID: S000074797
- Share class ID: C000233003
MSVEX Holdings
Top 10 holdings of Vitality Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Argenx SE | 8.03% |
| Eli Lilly & Co | 7.79% |
| Ascendis Pharma A/S | 5.48% |
| Nektar Therapeutics | 4.75% |
| Thermo Fisher Scientific Inc | 4.28% |
| Align Technology Inc | 4.18% |
| Enliven Therapeutics Inc | 3.90% |
| 10X Genomics Inc | 3.77% |
| Newamsterdam Pharma Co NV | 3.57% |
| Structure Therapeutics Inc | 3.36% |
MSVEX Portfolio Allocation
Asset-class allocation of Vitality Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 94.6% |
| Cash & Equivalents | 1.5% |
MSVEX Performance
Total returns for MSVEX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -8.1% |
| 1 year | 14.7% |
| 3 years (annualised) | -0.1% |
MSVEX Risk Information
Risk metrics for MSVEX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.6%
MSVEX Costs and Fees
MSVEX costs about $130 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.30%
- Gross expense ratio: 20.64%
- Portfolio turnover: 27%
- Brokerage commissions: 8.41 bps of average net assets (SEC N-CEN)
MSVEX Cashflows
Over the 12 months to 2026-03, Vitality Portfolio had net inflows of $34.43K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | $0 |
| 2026-02 | $0 |
| 2026-01 | −$20.91K |
| 2025-12 | $55.34K |
| 2025-11 | $0 |
| 2025-10 | $0 |
MSVEX Debt Constituents
No individual debt constituents are reported in Vitality Portfolio's latest SEC N-PORT filing.
MSVEX Prospectus and SEC Filings
Official Vitality Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-30
- Prospectus (485BPOS) — filed 2025-04-30
- Prospectus (485BPOS) — filed 2024-04-29
- Portfolio holdings (N-PORT) — filed 2026-05-28
- Portfolio holdings (N-PORT) — filed 2026-02-26
- Portfolio holdings (N-PORT) — filed 2025-11-26
- Annual census (N-CEN) — filed 2026-03-12
- Annual census (N-CEN) — filed 2025-03-07
Related Funds
Related funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.